Enrollment change • Trial completion date • Trial withdrawal • Trial primary completion date • Combination therapy • Epigenetic controller
|
BCL2 (B-cell CLL/lymphoma 2) • BCL6 (B-cell CLL/lymphoma 6)
|
BCL6 translocation
|
Keytruda (pembrolizumab) • zabinostat (CXD101)